GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Allied Corp (OTCPK:ALID) » Definitions » Future 3-5Y EPS without NRI Growth Rate

ALID (Allied) Future 3-5Y EPS without NRI Growth Rate : N/A (As of May. 05, 2025)


View and export this data going back to 2018. Start your Free Trial

What is Allied Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Allied's Future 3-5Y EPS without NRI Growth Rate is N/A.


Competitive Comparison of Allied's Future 3-5Y EPS without NRI Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Allied's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Allied's Future 3-5Y EPS without NRI Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Allied's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Allied's Future 3-5Y EPS without NRI Growth Rate falls into.


;
;

Allied  (OTCPK:ALID) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.


Allied Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Allied's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Allied Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Allied Corp (OTCPK:ALID) » Definitions » Future 3-5Y EPS without NRI Growth Rate
Traded in Other Exchanges
N/A
Address
200-460 Doyle Avenue, Kelowna, BC, CAN, V1Y OC2
Allied Corp is an international cannabis company with a mission to help people suffering from Post-Traumatic Stress Disorder (PTSD) by researching, creating, and producing targeted cannabinoid health solutions. The company uses an evidence-informed scientific approach to make this mission possible through cutting-edge pharmaceutical research and development, plant-based production, and the development of therapeutic products. The company operates in two segments which include Allied and Allied Colombia. Its geographical segments consist of Colombia and Canada. The company's revenue is comprised of sales of cannabis products.
Executives
James George Robinson director, 10 percent owner 10 EAST LEE STREET, SUITE 2705, BALTIMORE MD 21202
Anthony Zelen director, 10 percent owner 1406 MINE HILL LANE, KELOWNA A1 V1P 1S5
Calum Hughes director, 10 percent owner, officer: Chief Executive Officer 1847 CROSSGLEN COURT, KELOWNA A1 V1V 1S4
David Weinkauf director, 10 percent owner, officer: Chief Business Development Off 192 SIERRA MORENA LANDING, SW CALGARY A0 T3H 4K4
Paul James Bullock director, 10 percent owner, officer: Chief Operating Officer 1400 ST PAUL ST, SUITE 201, KELOWNA Z4 V1Y9N2

Allied Headlines

From GuruFocus